Loading...
Össur hf.
OSSUY•PNK
Healthcare
Medical - Devices
$4.00
$0.00(0.00%)
Össur hf. (OSSUY) Financial Performance & Income Statement Overview
Review Össur hf.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
8.81%
↑ 8.81%
Operating Income Growth
28.92%
↑ 28.92%
Net Income Growth
16.94%
↑ 16.94%
Operating Cash Flow Growth
23.05%
↑ 23.05%
Operating Margin
13.94%
↑ 13.94%
Gross Margin
62.19%
↑ 62.19%
Net Profit Margin
8.41%
↑ 8.41%
ROE
9.28%
↑ 9.28%
ROIC
8.87%
↑ 8.87%
Össur hf. (OSSUY) Income Statement & Financial Overview
Review Össur hf.'s (OSSUY) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $202.79M | $224.78M | $213.53M | $216.73M |
| Cost of Revenue | $75.02M | $82.66M | $79.92M | $86.75M |
| Gross Profit | $127.77M | $142.12M | $133.61M | $129.98M |
| Gross Profit Ratio | $0.63 | $0.63 | $0.63 | $0.60 |
| R&D Expenses | $10.57M | $11.005M | $9.50M | $9.15M |
| SG&A Expenses | $95.34M | $99.16M | $91.60M | $94.95M |
| Operating Expenses | $105.91M | $110.17M | $100.97M | $96.88M |
| Total Costs & Expenses | $180.93M | $192.83M | $180.89M | $183.63M |
| Interest Income | $674000.00 | $860000.00 | $903000.00 | $780000.00 |
| Interest Expense | $5.25M | $5.72M | $6.56M | $6.44M |
| Depreciation & Amortization | $14.24M | $14.64M | $13.93M | $13.81M |
| EBITDA | $34.53M | $44.19M | $47.96M | $46.91M |
| EBITDA Ratio | $0.17 | $0.20 | $0.22 | $0.22 |
| Operating Income | $21.86M | $31.95M | $32.64M | $33.10M |
| Operating Income Ratio | $0.11 | $0.14 | $0.15 | $0.15 |
| Other Income/Expenses (Net) | -$6.20M | -$7.07M | -$4.50M | -$6.54M |
| Income Before Tax | $15.66M | $24.88M | $28.14M | $25.68M |
| Income Before Tax Ratio | $0.08 | $0.11 | $0.13 | $0.12 |
| Income Tax Expense | $3.63M | $6.26M | $6.17M | $6.49M |
| Net Income | $12.16M | $18.21M | $21.86M | $19.95M |
| Net Income Ratio | $0.06 | $0.08 | $0.10 | $0.09 |
| EPS | $0.03 | $0.04 | $0.05 | $0.05 |
| Diluted EPS | $0.03 | $0.04 | $0.05 | $0.05 |
| Weighted Avg Shares Outstanding | $434.25M | $413.80M | $428.69M | $427.30M |
| Weighted Avg Shares Outstanding (Diluted) | $434.25M | $413.80M | $428.69M | $427.30M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan